Clinical trials

5

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Nexpowder™ for Diverticular Bleeding in the Lower Gastrointestinal Tract

Clinical Trial to Evaluate the Efficacy and Safety of Nexpowder™ for Diverticular Bleeding in the Lower Gastrointestinal Tract

Participants needed: 60
Trial details
Age: 19+Biological sex: AllType: InterventionalSponsor: Next Biomedical Co., Ltd.Updated: Apr 25, 2025Locations: 6
Eligibility criteria

Adults aged 19 years or older at the time of screening [+1]

Patients diagnosed with upper gastrointestinal bleeding

Status: Recruiting

Transcatheter Arterial Micro-Embolization (TAME) Using Nexsphere-F in Patients With Knee Degenerative Osteoarthritis

Among knee degenerative osteoarthritis patients aged 50 or older, it will prove the therapeutic effect and safety of Nexsphere-F embolization for patients who need additional treatment because pain is not controlled even if conventional treatments are taken.

Participants needed: 20
Trial details
Age: 50+Biological sex: AllType: InterventionalSponsor: Next Biomedical Co., Ltd.Updated: Apr 2, 2025Locations: 1
Eligibility criteria

Those who fall under Kellgren-Lawrence grade 2 to 3 according to the criteria in... [+4]

A locally infected patient [+11]

Status: Recruiting

Safety and Efficacy of Degradable Microsphere in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

The purpose of this study was to prospectively collect clinical data from patients who underwent hepatic artery chemoembolization using microspheres with different degradation times (2 hours, 1 day, 2 weeks) based on standard treatment.

Participants needed: 150
Trial details
Age: 19-79Biological sex: AllType: InterventionalSponsor: Next Biomedical Co., Ltd.Updated: Nov 14, 2024Locations: 1
Eligibility criteria

Adult patients aged 19 to 79 years [+5]

Patients under the age of 19 [+8]

Status: Recruiting

Transcatheter Arterial Micro-Embolization (TAME) Using Nexsphere-F in Patients With Chronic Pain in Elbow or Wrist

In patients with chronic elbow or wrist pain, the pain is controlled by conventional conservative therapy The pain reduction effect of Nexsphere-F embolization in patients who need additional treatment It is intended to demonstrate safety.

Participants needed: 38
Trial details
Age: 19-80Biological sex: AllType: InterventionalSponsor: Next Biomedical Co., Ltd.Updated: Mar 25, 2024Locations: 1
Eligibility criteria

Those aged 19 to 80 [+4]

Those with a VAS Score of less than 4 and Mild Elbow or Wrist Pain [+5]